Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, CSR, DIS, CXP, ESG

HIVENTURES INVESTS IN HUNGARIAN STARTUP THAT CREATES A FUTURE WITHOUT BARRIERS


Access4you provides detailed and reliable information on the accessibility of the built environment for people with disabilities and property owners. The Social Impact startup, founded in 2019, has a unified signage system that can help target groups around the world navigate while effectively supporting the business and sustainability (ESG) goals of companies. With an investment of EUR 950K from Hiventures, Hungary's most prevalent VC, the company is now expanding its partner network in international markets.

BUDAPEST, Hungary, Sept. 26, 2023 /PRNewswire/ -- According to the World Health Organization (WHO), 15% of the world's population ? around 1.3 billion people ? have a disability. To live an independent life, they must plan before accessing and navigating unfamiliar locations. 

Hiventures_Logo

"We believe that the first step in the (re)integration of people with disabilities is accessibility and reliable, detailed information on their environment. The access4you® certification mark ensures that certified accessibility information is available free of charge about the given location in our database, website, and mobile app to people with mobility, visual, hearing and cognitive impairments. It is not only good for society but for businesses. Property owners can use the certification mark to increase their property's value, have certified data in their ESG reports, while our accredited partners gain business opportunity with real social impact" - said Balázs Berecz, founder and CEO of Access4you, who is a wheelchair user for 15 years.

Accessibility and the lack of detailed, reliable information about it are global challenges. This is why Access4you began its international expansion in 2022 and in addition to Hungary, it already works in the Czech Republic, Romania, and India with the help of an accredited partner network including Colliers and Bureau Veritas. ?By expanding our international network of partners, we are working together to build a more barrier-free world" - added the founder.

?We seek to provide long term capital to support startups that have a positive impact on society or the environment, in addition to their economic results. Access4you fits perfectly within these parameters. The growing market trends, international scalability and close-knit team have all further motivated us to invest" - emphasized Dénes Szluha, Head of Hiventures' Startup Business Unit.

About Hiventures

Hiventures, part of the Hungarian MFB Group supports the entire Hungarian entrepreneurial eco-system with its capital and professional competencies, including innovative startups with large growth potential, traditional SMEs and major corporations.

Logo - https://mma.prnewswire.com/media/1028551/Hiventures_Logo.jpg

SOURCE Hiventures


These press releases may also interest you

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: